Top Story

Hormonal injection approved for treatment of hypoparathyroidism

January 26, 2015

The FDA recently approved a parathyroid hormone product to control hypocalcemia in patients with hypoparathyroidism, according to a press release.

The parathyroid hormone being marketed as Natpara (NPS Pharaceuticals, Inc.) is a hormonal injection administered once daily to help control calcium levels. It received orphan drug designation by the FDA because it is intended to treat a rare disease.

In the Journals

Social media interaction increased maintenance of weight loss

January 25, 2015
A significant drop in pounds, especially during the critical period following weight loss surgery, can be linked to use of a social media site, according to study…

Study underway of automated artificial pancreas to manage type 1 diabetes

January 24, 2015
Researchers at the Icahn School of Medicine at Mount Sinai are exploring whether an automated artificial pancreas could prevent hypoglycemia during sleep in patients…
Alberto Gutierrez FDA News

FDA allows marketing of first CGM mobile medical apps

January 23, 2015
The FDA today allowed marketing of the first set of mobile medical apps that allow patients with diabetes to automatically and securely share data from a continuous…
Xiaohui Zhuo In the Journals

Cost of managing diabetes per person doubled over 2 decades

January 23, 2015
Managing diabetes has become more costly in the past two decades, primarily because of increased spending on drugs, according to research published in Diabetes
More News Headlines »
CME
Acromegaly Cases

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is…
More »
Meeting News Coverage Video
Hatipoglu th

Autologous islet cell transplantation effective for chronic pancreatitis

December 3, 2014
In this video exclusive, Betul Hatipoglu, MD, clinical associate professor of medicine of the Endocrinology &…
More »
CME
Obesity Consults: Volume 2, Number 1

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Obesity is suboptimally managed in clinical practice despite the availability of relevantguidelines and evidence-based…
More »
Current Issues
View the Current Issues
morganatic-roan morganatic-roan